The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Li, Jun Jie ^a   Chen, Canming ^a   Gu, Yajia ^a   Di, Genhong ^a   Wu, Jiong ^a   Liu, Guangyu ^a   Shao, ZhiMin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CALCIFICATION; BREAST CANCER; BREAST MALFORMATION; BREAST SURGERY; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL DECISION MAKING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; TREATMENT RESPONSE; TUMOR CLASSIFICATION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CALCINOSIS; DECISION MAKING; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAMMOGRAPHY; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME;

EID: 84895510340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088853     Document Type: Article

References (41)

1. Redden MH, Fuhrman GM (2013) Neoadjuvant chemotherapy in the treatment of breast cancer. Surg Clin North Am 93: 493-499.
2. Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, et al. (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18: 1927-1934. (Pubitemid 350286227)
3. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, et al. (1988) Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62: 2507-2516. (Pubitemid 19006431)
4. Hortobagyi GN (1994) Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 74: 416-423.
5. Mauri D, Pavlidis N, Ioannidis JP (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97: 188-194. (Pubitemid 40277368)
6. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672-2685. (Pubitemid 28363030)
7. Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, et al. (2003) International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 21: 2600-2608. (Pubitemid 46606344)
8. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr: 96-102.
9. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, et al. (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224-4237. (Pubitemid 33081640)
10. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, et al. (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233: 830-849.
11. Smart CR, Byrne C, Smith RA, Garfinkel L, Letton AH, et al. (1997) Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 47: 134-149. (Pubitemid 27226280)
12. American College of Radiology (2003) Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston, Va: American College of Radiology.
13. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, et al. (1997) Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 3: 1565-1569. (Pubitemid 27431564)
14. Fiorentino C, Berruti A, Bottini A, Bodini M, Brizzi MP, et al. (2001) Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat 69: 143-151. (Pubitemid 33079021)
15. Hieken TJ, Harrison J, Herreros J, Velasco JM (2001) Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 182: 351-354. (Pubitemid 33079085)
16. Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM (2001) MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 13: 868-875. (Pubitemid 32479944)
17. Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, et al. (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181: 1275-1282. (Pubitemid 37296403)
18. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, et al. (2004) Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14: 1371-1379. (Pubitemid 39162217)
19. Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, et al. (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184: 868-877. (Pubitemid 43899515)
20. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, et al. (2006) Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243: 257-264. (Pubitemid 43185446)
21. Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, et al. (2010) Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg 199: 477-484.
22. Shin HJ, Kim HH, Ahn JH, Kim SB, Jung KH, et al. (2011) Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol 84: 612-620.
23. Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T (2011) Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol 18: 3160-3163.
24. Chen XS, Nie XQ, Chen CM, Wu JY, Wu J, et al. (2010) Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer. Ann Oncol 21: 961-967.
25. W. Fraser Symmans (2009) Pathologic Response Following Neoadjuvant Chemotherapy As An Outcome For Clinical And Translational Research. http://www.uscap.org/ site, /99th/pdf/companion11h02.pdf. Accessed 25 June 2013.
26. Peintinger F, Kuerer HM, Anderson K, Boughey JC, Meric-Bernstam F, et al. (2006) Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 13: 1443-1449. (Pubitemid 44749655)
27. Noguera JJ, de Luis E, Alonso-Burgos A, Viteri S, Zornoza G, et al. (2007) [Mammographic findings in microcalcifications associated with breast cancer after neoadjuvant chemotherapy]. Radiologia 49: 37-41.
28. Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE (1993) Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 47: 339-344. (Pubitemid 23152721)
29. Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, et al. (1996) Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198: 333-340. (Pubitemid 26036832)
30. Fadul D, Rapelyea J, Schwartz AM, Brem RF (2004) Development of malignant breast microcalcifications after neoadjuvant chemotherapy in advanced breast cancer. Breast J 10: 141-145. (Pubitemid 38375036)
31. Adwani A, Lowe S, Ebbs SR (2000) Disappearing microcalcification after neoadjuvant chemotherapy-a case report. Eur J Surg Oncol 26: 98-100. (Pubitemid 30102832)
32. Esserman LE, d'Almeida M, Da Costa D, Gerson DM, Poppiti RJ Jr (2006) Mammographic appearance of microcalcifications: can they change after neoadjuvant chemotherapy? Breast J 12: 86-87. (Pubitemid 43381459)
33. Ferranti C, Bergonzi S, Viganotti G, Piragine G, Barberini M, et al. (1992) [Microcalcifications in the diagnosis and follow-up after the primary chemotherapy of breast neoplasms]. Radiol Med 84: 26-31.
34. Segel MC, Paulus DD, Hortobagyi GN (1988) Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 169: 49-54.
35. Frappart L, Boudeulle M, Boumendil J, Lin HC, Martinon I, et al. (1984) Structure and composition of microcalcifications in benign and malignant lesions of the breast: study by light microscopy, transmission and scanning electron microscopy, microprobe analysis, and X-ray diffraction. Hum Pathol 15: 880-889. (Pubitemid 15125696)
36. Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, et al. (1999) Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 10: 47-52. (Pubitemid 29090591)
37. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, et al. (2001) Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182: 601-608. (Pubitemid 34142679)
38. Rouzier R, Extra JM, Carton M, Falcou MC, Vincent-Salomon A, et al. (2001) Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 19: 3828-3835. (Pubitemid 32880061)
39. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, et al. (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22: 2303-2312. (Pubitemid 41115386)
40. Shin HC, Han W, Moon HG, Im SA, Moon WK, et al. (2013) Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol 20: 2582-2589.
41. Kini VR, Vicini FA, Frazier R, Victor SJ, Wimbish K, et al. (1999) Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 43: 341-346. (Pubitemid 29091474)